Department of Internal Medicine, University of Manitoba.
University of Manitoba IBD Clinical and Research Center.
J Clin Gastroenterol. 2020 May/Jun;54(5):452-458. doi: 10.1097/MCG.0000000000001255.
There was some ambiguity in the recent guidelines on the use of capsule endoscopy (CE) in cases of iron deficiency anemia (IDA).
We aimed to examine the yield of CE in diagnosing the cause of IDA and to define clinical parameters that predict higher diagnostic yields.
A total of 1351 individuals underwent CE in Winnipeg between 2005 and 2016. All studies were reported by 1 reading physician. Data included demographics and requested information on medication use, prior imaging studies, and hemoglobin and ferritin levels. In a total of 620 (46%) patients, CE was indicated for occult gastrointestinal bleeding or IDA. Positive findings on CE were separated into "definite" and "possible." Multinomial regression analysis was used to determine the variables correlated with definite CE findings. A survey analysis was then used to assess how the study results impacted further management.
With regard to the 620 patients, the mean age was 62.9 years, mean hemoglobin level was 89 g/L, and median ferritin level was 9 μg/L. A total of 210 (33.9%) patients had positive findings (definite: 23%, possible: 10.8%). Vascular ectasias were the majority of definite findings (47.5%). Predictors of definite findings were age (relative risk ratio: 1.04; 95% confidence interval: 1.02-1.06) and male sex (relative risk ratio: 1.88; 95% confidence interval: 1.25-2.83). An overall 12.7% of positive studies required therapeutic intervention, with 65.8% undergoing further workup.
We report a 33.9% positive yield, with 65.8% of patients undergoing further workup as a result of CE and 12.7% requiring therapeutic intervention. We conclude that CE plays an important role in the investigation of IDA and occult gastrointestinal bleeding and has important implications on further management.
最近关于胶囊内镜(CE)在缺铁性贫血(IDA)病例中应用的指南存在一些模糊性。
我们旨在检查 CE 诊断 IDA 病因的检出率,并确定预测更高诊断检出率的临床参数。
2005 年至 2016 年期间,在温尼伯共有 1351 人接受了 CE 检查。所有研究均由 1 位阅读医师报告。数据包括人口统计学资料以及药物使用、先前的影像学研究以及血红蛋白和铁蛋白水平的相关信息。在总共 620 名(46%)患者中,CE 是为了隐匿性胃肠道出血或 IDA 而进行的。CE 的阳性发现分为“明确”和“可能”。采用多项回归分析确定与明确 CE 发现相关的变量。然后进行调查分析,以评估研究结果如何影响进一步的管理。
对于这 620 名患者,平均年龄为 62.9 岁,平均血红蛋白水平为 89g/L,中位铁蛋白水平为 9μg/L。共有 210 名(33.9%)患者有阳性发现(明确:23%,可能:10.8%)。明确发现中以血管扩张症为主(47.5%)。明确发现的预测因素为年龄(相对风险比:1.04;95%置信区间:1.02-1.06)和男性性别(相对风险比:1.88;95%置信区间:1.25-2.83)。阳性研究中有 12.7%需要治疗干预,其中 65.8%进一步进行了检查。
我们报告的阳性检出率为 33.9%,其中 65.8%的患者因 CE 进一步进行了检查,12.7%需要治疗干预。我们得出结论,CE 在 IDA 和隐匿性胃肠道出血的检查中发挥着重要作用,并对进一步的管理具有重要意义。